VPRIV

Details for Australian Trade Mark No. 1327294 (hide)

Owner Shire Human Genetic Therapies, Inc.

Convention US 8 September 2009 77821564

Various Convention priority claimed: 8 September 2009, United States of America, No. 77821564 in respect of PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF ENZYME DEFICIENCIES; PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF GAUCHER'S DISEASE in class 5.

Filing Date 16 September 2009

Classes

Class 5 Pharmaceutical preparations for the treatment of enzyme deficiencies; pharmaceutical preparations for the treatment of Gaucher's disease

Event Publications

12 November 2009 Application filed

14 January 2010 Application Accepted

6 May 2010 Trade Mark Registered/Protected

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the ATMOSS Australian Trade Mark On-line Search System.

Next and Previous Trademarks/Applications

1327295-LINABLUE

1327293-PrimeLub